Is treatment of insulin resistance beneficial independent of glycemia?

被引：10

作者：

Davidson, MB ^{[1
]}

机构：

[1] Charles R Drew Univ Med & Sci, Clin Trials Unit, Los Angeles, CA 90059 USA

来源：

DIABETES CARE | 2003年 / 26卷 / 11期

关键词：

D O I：

10.2337/diacare.26.11.3184

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3184 / 3186

页数：3

共 40 条

[1]

Agrawal A, 2002, DIABETES, V51, pA92

[2]

Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO

[3]

2-S

[4] Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes:: Evidence of an antiinflammatory action? [J].

Aljada, A ;

Garg, R ;

Ghanim, H ;

Mohanty, P ;

Hamouda, W ;

Assian, E ;

Dandona, P .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3250-3256

[5] Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study [J].

Aronoff, S ;

Rosenblatt, S ;

Braithwaite, S ;

Egan, JW ;

Mathisen, AL ;

Schneider, RL .

DIABETES CARE, 2000, 23 (11) :1605-1611

[6] The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: A placebo-controlled randomized clinical trial [J].

Caballero, AE ;

Saouaf, R ;

Lim, SC ;

Hamdy, O ;

Abou-Elenin, K ;

O'Connor, C ;

LoGerfo, FW ;

Horton, ES ;

Veves, A .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (02) :173-180

[7]

Choi SH, 2003, DIABETES, V52, pA19

[8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[9]

Cohn JN, 1999, J HYPERTENS, V17, pS41

[10] Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration, in NIDDM patients [J].

Cominacini, L ;

Garbin, U ;

Fratta Pasini, A ;

Campagnola, M ;

Davoli, A ;

Foot, E ;

Sighieri, G ;

Sironi, AM ;

Lo Cascio, V ;

Ferrannini, E .

DIABETES, 1998, 47 (01) :130-133

← 1 2 3 4 →